The Ethos Biosciences Mission
In science, quality is everything. Whether you’re uncovering basic insights into the inner workings of biological systems or are on the front lines of developing the next generation of therapeutics or diagnostics, you want your results to stand the test of time. But reliable, reproducible data doesn’t just happen on its own. It takes smart experimental design, skilled execution, and tools you can trust to deliver data that are both accurate and precise. And it also takes time.
At Ethos Biosciences, we want to give you back some of that time with assay kits, reagents, and services that are high quality, easy to use, and quick to implement. From well-thought-out kits designed to minimize preparatory steps and maximize accuracy, to expert support from the scientists that develop and manufacture each kit, to streamlined ordering, our goal is to simplify your path to the high-quality data that builds lasting and high-impact insights.
History: Built on a foundation of excellence
Ott Scientific: Manufacturing and selling scientific chemicals and reagents since 1993
Ott Scientific is a family-owned and operated group of specialty chemical manufacturing companies with expertise in monomers, polymers, microspheres, and reagents for the pharmaceutical, medical device, and diagnostic industries.
Ethos Biosciences was formed in 2018 as a subsidiary of Ott Scientific focused on the design, development, and manufacture of high-quality, easy-to-use assay kits, reagents, and services. In November of 2018, we acquired the Exocell® diagnostics operation from Glycadia, Inc., as a first step in assembling a world-class product catalog. With the Exocell acquisition, we not only incorporated the widely-cited products, many of which are considered the gold-standard assay in their respective areas, we’ve kept the entire operation. This means that current Exocell customers will continue to receive the same industry-leading products, services, and support that they’ve depended on since the company’s founding in 1988 by Margo Cohen, MD. Ph.D.
On July 12th, 2021, Ott Scientific combined legacy organizations into one business called Ethos Biosciences to better serve diagnostic customers seeking accurate, repeatable and easy-to-use products. The legacy organizations operate as product lines and service brands: American Bionostica for lateral flow products, Astral Diagnostics for histology and hematology stains and reagents, and Exocell for research and clinical nephrology assays. Combining our operations and areas of expertise has allowed us to seamlessly deliver contract development and manufacturing services to customers as well.
Our brand new state-of-the-art 127,000-square-foot Logan Township facility is expected to receive ISO13485:2016 certification in 2023.
